BridgeBio Pharma (BBIO) Capital Expenditures (QoQ) (2018 - 2026)
BridgeBio Pharma (BBIO) Capital Expenditures (QoQ) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | BridgeBio Pharma | 16.15 Bn | 15.22 Bn | 184.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -93.64% |
| Dec 31, 2025 | 8,941.67% |
| Dec 31, 2024 | -97.55% |
| Sep 30, 2024 | 132.64% |
| Jun 30, 2024 | -189.93% |
| Mar 31, 2024 | 855.43% |
| Dec 31, 2023 | 62.90% |
| Sep 30, 2023 | -157.94% |
| Jun 30, 2023 | 3,466.67% |
| Mar 31, 2023 | -99.75% |
| Dec 31, 2022 | 248.73% |
| Sep 30, 2022 | -227.48% |
| Jun 30, 2022 | 234.80% |
| Mar 31, 2022 | -93.05% |
| Dec 31, 2021 | 700.17% |
| Sep 30, 2021 | -173.10% |
| Jun 30, 2021 | 37.72% |
| Mar 31, 2021 | 133.27% |
| Dec 31, 2020 | -1,078.51% |
| Sep 30, 2020 | 58.67% |